Verity & Verity’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.1M Sell
115,139
-1,554
-1% -$362K 2.1% 18
2025
Q4
$24.1M Buy
116,693
+1,770
+2% +$350K 1.88% 15
2025
Q3
$21.3M Buy
114,923
+1,441
+1% +$247K 1.71% 17
2025
Q2
$17.3M Sell
113,482
-14
-0% -$2.15K 1.49% 27
2025
Q1
$18.8M Buy
113,496
+7,411
+7% +$1.16M 1.65% 25
2024
Q4
$15.3M Buy
106,085
+10,050
+10% +$1.56M 1.4% 30
2024
Q3
$15.6M Buy
96,035
+644
+0.7% +$103K 1.52% 29
2024
Q2
$13.9M Buy
95,391
+7,706
+9% +$1.15M 1.52% 29
2024
Q1
$13.9M Sell
87,685
-3,017
-3% -$480K 1.54% 30
2023
Q4
$14.2M Buy
90,702
+1,758
+2% +$270K 1.63% 24
2023
Q3
$13.9M Buy
88,944
+2,077
+2% +$343K 1.74% 24
2023
Q2
$14.4M Buy
86,867
+2,758
+3% +$445K 1.76% 24
2023
Q1
$13M Buy
84,109
+4,317
+5% +$697K 1.66% 23
2022
Q4
$14.1M Buy
79,792
+5,181
+7% +$895K 1.84% 19
2022
Q3
$12.2M Buy
74,611
+3,210
+4% +$543K 1.96% 18
2022
Q2
$12.7M Buy
71,401
+339
+0.5% +$60.4K 1.94% 18
2022
Q1
$12.6M Buy
71,062
+3,278
+5% +$558K 1.75% 24
2021
Q4
$11.6M Buy
67,784
+1,579
+2% +$259K 1.66% 28
2021
Q3
$10.9M Buy
66,205
+1,610
+2% +$275K 1.64% 28
2021
Q2
$10.6M Buy
64,595
+72
+0.1% +$11.9K 1.68% 27
2021
Q1
$10.5M Buy
64,523
+5,364
+9% +$868K 1.69% 25
2020
Q4
$9.43M Buy
59,159
+5,892
+11% +$869K 1.78% 21
2020
Q3
$7.9M Buy
53,267
+1,854
+4% +$274K 1.74% 23
2020
Q2
$7.47M Buy
51,413
+1,527
+3% +$223K 1.78% 22
2020
Q1
$6.54M Sell
49,886
-6,523
-12% -$925K 1.84% 19
2019
Q4
$8.23M Sell
56,409
-249
-0.4% -$33.8K 1.6% 22
2019
Q3
$7.32M Sell
56,658
-25,184
-31% -$3.32M 1.55% 24
2019
Q2
$11.4M Buy
81,842
+455
+0.6% +$63K 2.48% 5
2019
Q1
$11.4M Buy
81,387
+6,967
+9% +$933K 2.61% 3
2018
Q4
$9.6M Buy
74,420
+470
+0.6% +$65.6K 2.57% 5
2018
Q3
$10.2M Sell
73,950
-1,050
-1% -$140K 2.46% 8
2018
Q2
$9.1M Buy
75,000
+2,011
+3% +$251K 2.36% 11
2018
Q1
$9.35M Buy
72,989
+983
+1% +$133K 2.52% 9
2017
Q4
$10.1M Sell
72,006
-1,084
-1% -$151K 2.71% 4
2017
Q3
$9.5M Buy
73,090
+1,378
+2% +$183K 2.77% 2
2017
Q2
$9.49M Sell
71,712
-2,584
-3% -$330K 2.91% 1
2017
Q1
$9.25M Buy
74,296
+2,678
+4% +$320K 2.88% 1
2016
Q4
$8.25M Buy
71,618
+2,681
+4% +$310K 2.87% 2
2016
Q3
$8.14M Buy
68,937
+863
+1% +$105K 2.99% 1
2016
Q2
$8.26M Buy
68,074
+1,006
+1% +$114K 3.18% 1
2016
Q1
$7.26M Buy
67,068
+810
+1% +$83.9K 3.08% 1
2015
Q4
$6.81M Buy
66,258
+1,357
+2% +$136K 3.09% 1
2015
Q3
$6.06M Buy
+64,901
New +$6.28M 2.97% 1
2015
Q2
Sell
-43,002
Closed -$4.33M 63
2015
Q1
$4.33M Buy
43,002
+1,873
+5% +$190K 1.98% 22
2014
Q4
$4.3M Buy
41,129
+467
+1% +$49.2K 2.04% 17
2014
Q3
$4.33M Buy
40,662
+185
+0.5% +$19.2K 2.17% 5
2014
Q2
$4.23M Buy
40,477
+1,193
+3% +$121K 2.17% 10
2014
Q1
$3.86M Buy
39,284
+1,219
+3% +$113K 2.09% 13
2013
Q4
$3.49M Sell
38,065
-1,622
-4% -$149K 1.93% 19
2013
Q3
$3.44M Buy
39,687
+611
+2% +$54.8K 1.98% 13
2013
Q2
$3.35M Buy
+39,076
New +$3.32M 2.05% 7

Other funds holding JNJ

Verity & Verity's JNJ Position: Q1 2026 in Review

Verity & Verity reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q1 2026, selling an estimated $362K and leaving 115,139 shares worth $28.1M. The position accounts for 2.1% of the portfolio, ranked #18.

Verity & Verity first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Verity & Verity held 115,139 shares of Johnson & Johnson worth $28.1M as of Q1 2026.
  • Verity & Verity sold 1,554 Johnson & Johnson shares in Q1 2026, an estimated $362K.
  • Johnson & Johnson made up 2.1% of Verity & Verity's portfolio in Q1 2026, its #18 holding.
  • Verity & Verity first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Verity & Verity's 13F filing for Q1 2026, filed 15 Apr 2026.